Suppr超能文献

两例结节病-淋巴瘤综合征。

Two cases of sarcoidosis-lymphoma syndrome.

作者信息

Suvajdzic Nada, Milenkovic Branislava, Perunicic Maja, Stojsic Jelena, Jankovic Snezana

机构信息

Institute of Hematology, Clinical Center of Serbia, 2 Koste Todorovic Str., Belgrade, Serbia and Montenegro.

出版信息

Med Oncol. 2007;24(4):469-71. doi: 10.1007/s12032-007-0026-8.

Abstract

An association between sarcoidosis and lymphoproliferative diseases (LD), the sarcoidosis-lymphoma syndrome, has been previously described, and may be attributed to the underlying immunological abnormalities that occur during the sarcoidosis disease process. We report two patients who developed Hodgkin's disease and diffuse large B-cell non-Hodgkin's lymphoma (NHL) subsequent to their diagnosis of sarcoidosis after latency periods of 6 years and 18 years respectively. Both patients developed histologically-proven sarcoidosis late in life, at 46 years and 58 years, and had differing clinical courses. The first had radiographically staged II chronic progressive respiratory sarcoidosis (RS) and required long-term methotrexate to control the disease, while the second achieved a spontaneous remission of her stage I intrathoracic RS. After treatment, the patient with Hodgkin's disease remains in remission 2.5 years following six cycles of ABVD protocol chemotherapy and involved-field radiotherapy, while the NHL patient remains in remission at 3 years following six cycles of R-COP protocol chemotherapy. Clinicians should be aware of the potential risks of malignancy, and especially of LD in sarcoidosis patients. They should be alerted to the possibility of additional pathology by any atypical clinical features, and should biopsy new lesions and adenopathy to exclude any coexistent neoplasm.

摘要

结节病与淋巴增殖性疾病(LD)之间存在关联,即结节病 - 淋巴瘤综合征,此前已有描述,这可能归因于结节病病程中发生的潜在免疫异常。我们报告了两名患者,他们分别在诊断结节病6年和18年的潜伏期后,患上了霍奇金病和弥漫性大B细胞非霍奇金淋巴瘤(NHL)。两名患者均在晚年发病,分别为46岁和58岁,经组织学证实患有结节病,且临床病程不同。第一名患者经影像学分期为II期慢性进行性呼吸性结节病(RS),需要长期使用甲氨蝶呤来控制病情,而第二名患者的I期胸内RS实现了自发缓解。治疗后,霍奇金病患者在接受六个周期的ABVD方案化疗和受累野放疗后2.5年仍处于缓解期,而非霍奇金淋巴瘤患者在接受六个周期的R - COP方案化疗后3年仍处于缓解期。临床医生应意识到结节病患者发生恶性肿瘤的潜在风险,尤其是LD的风险。他们应警惕任何非典型临床特征提示的额外病理情况,并应对新病变和淋巴结病进行活检,以排除任何并存的肿瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验